HuGE Literature Finder
Records
1
-
2
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 2023 1 . Michot Jean-Marie, Quivoron Cyril, Sarkozy Clémentine, Danu Alina, Lazarovici Julien, Saleh Khalil, El-Dakdouki Yolla, Goldschmidt Vincent, Bigenwald Camille, Dragani Matteo, Bahleda Rastislav, Baldini Capucine, Arfi-Rouche Julia, Martin-Romano Patricia, Tselikas Lambros, Gazzah Anas, Hollebecque Antoine, Lacroix Ludovic, Ghez David, Vergé Veronique, Marzac Christophe, Cotteret Sophie, Rahali Wassila, Soria Jean-Charles, Massard Christophe, Bernard Olivier A, Dartigues Peggy, Camara-Clayette Valérie, Ribrag Vince |
MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. Blood advances 2019 2 3 (3): 375-383. Nayyar Naema, White Michael D, Gill Corey M, Lastrapes Matthew, Bertalan Mia, Kaplan Alexander, D'Andrea Megan R, Bihun Ivanna, Kaneb Andrew, Dietrich Jorg, Ferry Judith A, Martinez-Lage Maria, Giobbie-Hurder Anita, Borger Darrell R, Rodriguez Fausto J, Frosch Matthew P, Batchelor Emily, Hoang Kaitlin, Kuter Benjamin, Fortin Sarah, Holdhoff Matthias, Cahill Daniel P, Carter Scott, Brastianos Priscilla K, Batchelor Tracy |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: